GI
TEVA icon

GLG Inc’s Teva Pharmaceuticals TEVA Stock Holding History

GLG Inc’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$1.17M Sell
29,194
-150,671
-84% -$5.93M 0.03% 471
2013
Q3 		$6.79M Buy
179,865
+140,293
+355% +$5.47M 0.13% 201
2013
Q2 		$1.55M Buy
+39,572
New +$1.54M 0.04% 364

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GLG Inc's TEVA Position: Q4 2013 in Review

GLG Inc reduced its Teva Pharmaceuticals (TEVA) stake by 84% in Q4 2013, selling an estimated $5.93M and leaving 29,194 shares worth $1.17M. The position accounts for 0.03% of the portfolio, ranked #471.

GLG Inc first reported a position in TEVA in Q2 2013 and has held it in 3 quarters since. The position peaked at $6.79M in Q3 2013. 727 funds tracked by Wall St. Rank hold TEVA as of Q4 2013.

  • GLG Inc held 29,194 shares of Teva Pharmaceuticals worth $1.17M as of Q4 2013.
  • GLG Inc sold 150,671 Teva Pharmaceuticals shares in Q4 2013, an estimated $5.93M.
  • Teva Pharmaceuticals made up 0.03% of GLG Inc's portfolio in Q4 2013, its #471 holding.
  • GLG Inc first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 3 quarters since.
  • GLG Inc's Teva Pharmaceuticals position peaked at $6.79M in Q3 2013.
  • 727 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2013.

Based on GLG Inc's 13F filing for Q4 2013, filed 14 Feb 2014.